Heat Biologics Inc reports results for the quarter ended in September - Earnings Summary

Scorpius Holdings

11/11/2021 24:22

* Heat Biologics Inc  HTBX.OQ  reported a quarterly adjusted
loss of 30 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 30 cents per share.
* Revenue fell 41% to $501.57 thousand from a year ago; 
analysts expected $450.00 thousand. 
* Heat Biologics Inc's reported EPS for the quarter was a loss
of 30 cents​.
* The mean earnings estimate of analysts had risen by about 3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Heat Biologics Inc shares had fallen by 11.1% this quarter and
lost 1.3% so far this year.
* The company reported a quarterly loss of $7.43 million.
* Wall Street's median 12-month price target for Heat Biologics
Inc is $19.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 12:22 a.m.
 ​All figures in US dollars unless otherwise stated